JAK inhibitors offer effective and convenient treatment option for arthritis patients

According to a new paper in Rheumatology, published by Oxford University Press, JAK inhibitors, which doctors have used to treat patients with arthritis despite concerns about the effectiveness of such drugs, actually do work quite well.

CVS Health sees Medicare Advantage patients seek more care, eating into profits

Medicare Advantage members continue to go to the doctor and get health care procedures a lot more than predicted, CVS Health executives said at the

January 8, 2024

Dizal seeks FDA approval for NSCLC treatment sunvozertinib

The NDA submission is bolstered by data from the WU-KONG1 Part B trial. Credit: Jo Panuwat D via Shutterstock. Dizal has submitted sunvozertinib’s new drug

November 11, 2024

Roche records 4% decline in H1 2024 net income

Roche’s Pharmaceuticals division’s base business expanded by 8% to SFr22.6bn from SFr22.5bn. Credit: F. Hoffmann-La Roche Ltd. Roche has reported a net income of SFr6.6bn

July 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.